A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/16 (2006.01) A61K 38/28 (2006.01) A61P 3/10 (2006.01)
Patent
CA 2428159
The invention relates to a pharmaceutical delayed-release formulation containing proinsulin C-peptide and the use of the delayed-release formulations for treating complications of diabetes. In particular, the invention relates to delayed-release formulations in which proinsulin C- peptide is present in an absorbable matrix consisting for example of absorbable polymers. The invention also relates to microparticles which contain proinsulin C-peptide.
L'invention a trait à une préparation pharmaceutique à action retardée comportant le peptide-C de la pro-insuline, ainsi qu'à l'utilisation de ces préparations à action retardée dans le traitement des complications du diabète. L'invention concerne, en particulier, des préparations à action retardée dans lesquelles le peptide-C de la pro-insuline est présent dans une matrice absorbable constituée, par exemple, de polymères absorbables. L'invention concerne également des microparticules qui contiennent le peptide-C de la pro-insuline.
Mohr Detlef
Seiffert Tim
Creative Peptides Sweden Ab
Fetherstonhaugh & Co.
LandOfFree
Delayed-release pharmaceutical formulations containing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Delayed-release pharmaceutical formulations containing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Delayed-release pharmaceutical formulations containing... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2042246